BROADCASTS.com

Sher Ali Butt, CEO, CB Therapeutics was presenting at a recent University of California San Diego IGNITE Innovator & Entrepreneur conference.  He was there to highlight their novel way of producing cannabinoids in yeast bypassing the need for land, water and other elements involved with growing cannabis plants to extract the cannabinoids.  Using biosynthesis technologies they are able to produce CBD isolate with a high level of purity in under 6 days costing on average $5/gram of pure compounds.  Now it is up to the medical profession to find new ways to use CBD instead of opiates and other pain medications.

@CBTherapeutics 

CB Therapeutics